# HEPARIN SODIUM
> **ANDA203851** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-11-30
## Drug
- **FDA Application Number:** ANDA203851
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HEPARIN SODIUM
- **Generic name:** HEPARIN SODIUM
- **Active ingredients:** HEPARIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2017-11-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203851)
---
*AI Analytics · CC0 1.0*